Sana Biotechnology (SANA) Leases (2020 - 2026)

Sana Biotechnology's Leases history runs 7 years deep, the most recent figure standing at $35.8 million for Q1 2026.

• In Q1 2026, Leases fell 34.63% year-over-year to $35.8 million; the TTM figure through Mar 2026 stood at $35.8 million (down 34.63% YoY), while the FY2025 annual figure was $38.3 million, down 33.9% from the prior year.
• Leases came in at $35.8 million for Q1 2026 at Sana Biotechnology, down from $38.3 million in the prior quarter.
• In the past five years, Leases ranged from a high of $98.9 million in Q2 2022 to a low of $35.8 million in Q1 2026.
• A 5-year average of $70.3 million and a median of $71.6 million in 2024 frame the typical range for Leases.
• Across the five-year window, Leases surged 63.95% in 2022 and sank 34.63% in 2026, its largest moves.
• Sana Biotechnology's Leases stood at $92.5 million in 2022, then dropped by 19.01% to $74.9 million in 2023, then fell by 22.62% to $58.0 million in 2024, then tumbled by 33.9% to $38.3 million in 2025, then declined by 6.44% to $35.8 million in 2026.
• According to Business Quant data, Leases over the past three periods registered $35.8 million, $38.3 million, and $40.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison